Skip to main content
Fig. 5 | Cardiovascular Diabetology

Fig. 5

From: Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitor

Fig. 5

Subgroup analysis of hazard ratios for the risk of major adverse lower limb events including lower limb revascularization procedure (a) and amputation (b) for SGLT2i versus DPP4i among T2DM patients with concomitant with peripheral artery disease after propensity score matching. The subgroup analysis revealed consistent results for lower limb revascularization (a) or amputation (b) for SGLT2i versus DPP4i among patients aged ≥ 75 years, the presence of CKD and established CV disease, consistent with the main analysis (all p interactions > 0.05). The abbreviations are the same as those in Figs. 1, 2, 3, 4

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840